InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $0.09 · Revenue $252.13M · 1 analysts
Est. EPS $0.10 · Revenue $256.50M · 1 analysts
Est. EPS $0.13 · Revenue $267.22M · 1 analysts
Est. EPS $0.44 · Revenue $1.04B · 2 analysts
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $853.7M | +11.8% | +5.1% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-30.3M | -42.1% | -377.5% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +68.5% | +296.2% | +11.5% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -3.5% | -14.9% | +34.6% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -3.6% | -27.1% | -364.0% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $26.6M | +159.4% | -23.1% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +3.1% | +153.1% | -26.8% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 43.0% | +2.5% | -10.1% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 1.07x | -14.5% | -17.7% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $557.2M | -3.9% | +3.8% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -0.22 vs -0.17 | -26.6% | -0.22 vs 0.06 | -497.1% |
| Revenue Surprise | $853.7M vs $852.0M | +0.2% | $251.9M vs $234.3M | +7.5% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Taheri Paul | officer: Chief Medical Officer | Common Stock, $0.001 par value | — | 0 | — |
| Jul 27, 2026 | BLAIR PATRICK T | officer: CHIEF EXECUTIVE OFFICER | Common Stock, $0.001 par value | A | 78,397 | — |
| Jul 22, 2026 | Adams Benjamin C | officer: CHIEF FINANCIAL OFFICER | Common Stock, $0.001 par value | A | 17,123 | — |
| Jul 22, 2026 | DAMATO NICOLE | officer: CHIEF LEGAL OFFICER | Common Stock, $0.001 par value | A | 51,369 | — |
| Jul 22, 2026 | Delk Meredith | officer: Chief Administrative Officer | Common Stock, $0.001 par value | A | 42,808 | — |
Operator: Good day, and thank you for standing by. Welcome to the InnovAge 2026 Fiscal Third Quarter Earnings Call. [Operator Instructions] Please be advised today's conference is being recorded. I would like to hand the conference over to your speaker today, Ryan Kubota. Please go ahead. Ryan Kubota: Thank you, operator. Good afternoon, and thank you all for joining the InnovAge 2026 Fiscal Third Quarter Earnings Call. With me today is Patrick Blair, CEO; and Ben Adams, CFO. Today, after the market closed, we issued an earnings press release containing detailed information on our fiscal third quarter results. You may access the release on the Investor Relations section of our company website, innovage.com. For those listening to the rebroadcast of this call, we remind you that the remarks made herein are as of today, Tuesday, May 5, 2026, and have not been updated subsequent to this call. During our call, we will refer to certain non-GAAP measures. A reconciliation of these measures to the most directly comparable GAAP measures can be found in our earnings press release posted on our website. We will also make statements that are considered forward-looking, including those related to our 2026 fiscal year projections and guidance, future growth prospects and growth strategy, our clinical and operational value initiatives, the effects of recent legislation and federal budget cuts, including Medicare and Medicaid rate pressures, seasonality of cost trends, the status of current and future legal proceedings and regulatory actions and other expectations. Listeners are cautioned that all of our forward-looking statements involve certain assumptions that are inherently subject to risks and uncertainties that can cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors and other discussions included in our annual report on Form 10-K for fiscal year 2025 and any subsequent reports filed with the SEC, including our most recent quarterly report on Form 10-Q. After the completion of our prepared remarks, we will open the call for questions. I will now turn the call over to our CEO, Patrick Blair. Patrick? Patrick Blair: Thank you, Ryan, and good afternoon, everyone. I'd like to begin by thanking our InnovAge colleagues, our participants and their families, our government partners and our investor community for your continued trust and support. The work our teams do every day to care for a very complex and vulnerable population is what drives our performance, and I'm proud of the progress we're making and the consistency we're beginning to demonstrate as an organization. We delivered a solid third quarter and continue to see steady momentum across the business. These results reflect stronger operating execution and the benefits of the investments we've made over the past few years to strengthen the platform. For the quarter, we reported approximately $252 million in total revenue, …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Patrick Blair | Chief Executive Officer | USD 1,547,000 | Male | 1971 | Active |
Jennifer Browne | President & Chief Operating Officer | USD 851,992 | Female | — | Active |
Nicole D'Amato | Chief Legal Officer & Corporate Secretary | USD 766,120 | Female | 1979 | Active |
Benjamin Crowninshield Adams | Chief Financial Officer | USD 699,665 | Male | 1964 | Active |
Edward Moore Kennedy Jr. | Independent Director | USD 100,000 | Male | 1961 | Active |
Marilyn Barbour Tavenner | Independent Director | USD 100,000 | — | 1952 | Active |
Ryan Kubota | Director of Investor Relations | — | Male | — | Active |
Meredith Delk | Executive Vice President & Chief Administrative Officer | — | Female | 1973 | Active |
Olivia Patton | Chief Compliance Officer | — | Female | — | Active |
Dustin Lee | Chief People Officer | — | Male | — | Active |
Cara Babachicos | Chief Information Officer | — | Female | — | Active |
Algert Global LLC grew its position in shares of InnovAge Holding Corp. (NASDAQ: INNV) by 844.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 630,520 shares of the company's stock after buying an additional 563,735 shares during the period. Algert Global
DENVER, Aug. 26, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2026 fiscal fourth quarter and full year financial results on Tuesday, September 8, 2026, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m.
On August 11, 2026, InnovAge Holding Corp (INNV) shares fell 6.4% to $10.23, reflecting a volatile price performance that has seen a 52-week range from $3.26 to
Arrowstreet Capital Limited Partnership bought a new stake in InnovAge Holding Corp. (NASDAQ: INNV) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 417,538 shares of the company's stock, valued at approximately $3,349,000. Arrowstreet Capital Limited Partnership owned about 0.31% of InnovAge
